Corporate Action8 Sept 2026, 10:20 pm
Anthem Biosciences Settles Upside Sharing Arrangement for ₹1,276.83 Million
AI Summary
Anthem Biosciences Ltd has announced the settlement of its Upside Sharing Arrangement, as approved by shareholders at the AGM on July 22, 2026. This arrangement, stemming from a December 30, 2024 agreement, involved the divestment by Viridity Tone LLP. Approximately INR 1,276.83 million has been settled with the Upside Principal Shareholders: Mr. Ajay Bhardwaj, Mr. Ganesh Sambasivam, and Mr. K. Ravindra Chandrappa. This action is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Upside Sharing Arrangement settled for INR 1,276.83 million.
- Settlement follows shareholder approval at the July 22, 2026 AGM.
- Arrangement relates to divestment by Viridity Tone LLP.
- Payment made to principal shareholders Mr. Bhardwaj, Mr. Sambasivam, and Mr. Chandrappa.
Price Impact
More from ANTHEM